As part of our series focussing on medicines available in Australia, we have added a product review of the use of immunoglobulin products for primary immunodeficiency diseases and chronic inflammatory demyelinating polyneuropathy.
This review discusses two different products, their indications and dosage, contraindications and a series of clinical studies featuring their use. It provides commentary from Associate Professor Sean Riminton, a Clinical Immunologist in Sydney, and Associate Professor Todd Hardy, a Senior Staff Specialist Neurologist in the Multiple Sclerosis and Neuroimmunology Clinics at Concord Hospital.
Please login below to download this issue (PDF)